![]() |

![]() |
Create Name: | |
Description: |
![]() |
Save what matters to you |
{{ loginError }} |
Sign in with your RGD account |
Create New Account | Recover Password |
Analyze GeneStrainQTL List |
![]() Gene Annotator (Functional Annotation) unavailable |
![]() Gene Annotator (Annotation Distribution) unavailable |
![]() Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
![]() InterViewer (Protein-Protein Interactions) unavailable |
![]() Gviewer (Genome Viewer) unavailable |
![]() Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
![]() Gene Annotator (Annotation Comparison) unavailable |
![]() OLGA (Gene List Generator) unavailable |
![]() |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
![]() MOET (Multi-Ontology Enrichement) unavailable |
![]() GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
![]() Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of VMP1 mRNA | CTD | PMID:24758408 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of VMP1 mRNA, EGF protein inhibits the reaction [Estradiol results in decreased expression of VMP1 mRNA] | CTD | PMID:24758408, PMID:30165855 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | EXP | | 6480464 | Dihydrotestosterone results in increased expression of VMP1 mRNA | CTD | PMID:23052036 | 2,2',5,5'-tetrachlorobiphenyl | decreases expression | ISO | RGD:70367 | 6480464 | 2 more ... | CTD | PMID:23829299 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:70367 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of VMP1 mRNA | CTD | PMID:16054898 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of VMP1 mRNA | CTD | PMID:26238291 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1619944 | 6480464 | Tetrachlorodibenzodioxin affects the expression of VMP1 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of VMP1 mRNA | CTD | PMID:22298810 | 2-butoxyethanol | increases expression | ISO | RGD:1619944 | 6480464 | n-butoxyethanol results in increased expression of VMP1 mRNA | CTD | PMID:19812364 | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of VMP1 mRNA | CTD | PMID:30851411 | 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:70367 | 6480464 | 1, 2-dithiol-3-thione results in decreased expression of VMP1 mRNA | CTD | PMID:19162173 | 6-propyl-2-thiouracil | decreases expression | ISO | RGD:70367 | 6480464 | Propylthiouracil results in decreased expression of VMP1 mRNA | CTD | PMID:24780913 | actinomycin D | decreases expression | EXP | | 6480464 | Dactinomycin results in decreased expression of VMP1 mRNA | CTD | PMID:23052036 | actinomycin D | multiple interactions | EXP | | 6480464 | [Dactinomycin co-treated with fludioxonil] results in decreased expression of VMP1 mRNA more ... | CTD | PMID:23052036, PMID:25969534 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of VMP1 mRNA | CTD | PMID:21641981 | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of VMP1 intron | CTD | PMID:30157460 | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of VMP1 gene | CTD | PMID:27153756 | ammonium chloride | affects expression | ISO | RGD:70367 | 6480464 | Ammonium Chloride affects the expression of VMP1 mRNA | CTD | PMID:16483693 | amphetamine | increases expression | ISO | RGD:70367 | 6480464 | Amphetamine results in increased expression of VMP1 mRNA | CTD | PMID:30779732 | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of VMP1 mRNA | CTD | PMID:24449571 | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of VMP1 mRNA | CTD | PMID:17690111 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of VMP1 mRNA | CTD | PMID:16269432 more ... | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:20018196 | benzo[b]fluoranthene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of VMP1 mRNA | CTD | PMID:17690111 | benzo[b]fluoranthene | increases expression | EXP | | 6480464 | benzo(b)fluoranthene results in increased expression of VMP1 mRNA | CTD | PMID:16269432 | bisphenol A | increases expression | ISO | RGD:70367 | 6480464 | bisphenol A results in increased expression of VMP1 mRNA | CTD | PMID:25181051 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of VMP1 mRNA | CTD | PMID:30903817 | cadmium atom | increases expression | ISO | RGD:1619944 | 6480464 | Cadmium results in increased expression of VMP1 mRNA, Cadmium results in increased expression of VMP1 protein | CTD | PMID:30985881 | cadmium atom | multiple interactions | EXP | | 6480464 | VMP1 affects the reaction [Cadmium results in increased cleavage of and results in increased activity of CASP3 protein], VMP1 affects the reaction [Cadmium results in increased cleavage of PARP1 protein] | CTD | PMID:30985881 | cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of VMP1 mRNA, Cadmium results in increased expression of VMP1 protein | CTD | PMID:30985881 | carbon nanotube | increases expression | ISO | RGD:1619944 | 6480464 | Nanotubes, Carbon analog results in increased expression of VMP1 mRNA, Nanotubes, Carbon results in increased expression of VMP1 mRNA | CTD | PMID:25554681, PMID:25620056 | choline | multiple interactions | ISO | RGD:1619944 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VMP1 gene | CTD | PMID:20938992 | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of VMP1 mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of VMP1 mRNA | CTD | PMID:25562108 | DDT | increases expression | EXP | | 6480464 | DDT results in increased expression of VMP1 mRNA | CTD | PMID:25014179 | dehydroepiandrosterone | increases expression | EXP | | 6480464 | Dehydroepiandrosterone results in increased expression of VMP1 mRNA | CTD | PMID:25969534 | dehydroepiandrosterone | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Dehydroepiandrosterone results in increased expression of VMP1 mRNA] more ... | CTD | PMID:25969534 | dibenz[a,h]anthracene | increases expression | EXP | | 6480464 | 1 more ... | CTD | PMID:16269432 | dibutyl phthalate | increases expression | ISO | RGD:1619944 | 6480464 | Dibutyl Phthalate results in increased expression of VMP1 mRNA | CTD | PMID:21266533 | dibutyl phthalate | increases expression | ISO | RGD:70367 | 6480464 | Dibutyl Phthalate results in increased expression of VMP1 mRNA | CTD | PMID:21266533 | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of VMP1 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VMP1 mRNA | CTD | PMID:27188386 | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of VMP1 mRNA | CTD | PMID:29803840 | ethanol | affects splicing | ISO | RGD:1619944 | 6480464 | Ethanol affects the splicing of VMP1 mRNA | CTD | PMID:30319688 | fenbuconazole | increases expression | EXP | | 6480464 | fenbuconazole results in increased expression of VMP1 mRNA | CTD | PMID:15942997 | fenhexamid | multiple interactions | EXP | | 6480464 | Dactinomycin inhibits the reaction [N-(2, 3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of VMP1 mRNA] | CTD | PMID:23052036 | fenhexamid | increases expression | EXP | | 6480464 | N-(2, 3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of VMP1 mRNA | CTD | PMID:23052036 | fludioxonil | multiple interactions | EXP | | 6480464 | [Dactinomycin co-treated with fludioxonil] results in decreased expression of VMP1 mRNA | CTD | PMID:23052036 | fluoranthene | increases expression | EXP | | 6480464 | fluoranthene results in increased expression of VMP1 mRNA | CTD | PMID:16269432 | folic acid | multiple interactions | ISO | RGD:1619944 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VMP1 gene | CTD | PMID:20938992 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of VMP1 mRNA | CTD | PMID:27664576 | geldanamycin | increases expression | EXP | | 6480464 | geldanamycin results in increased expression of VMP1 mRNA | CTD | PMID:26705709 | gemcitabine | increases expression | EXP | | 6480464 | gemcitabine results in increased expression of VMP1 | CTD | PMID:20299819 | hypochlorous acid | increases expression | ISO | RGD:1619944 | 6480464 | Hypochlorous Acid results in increased expression of VMP1 mRNA | CTD | PMID:19376150 | indometacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of VMP1 mRNA | CTD | PMID:16984733 | isotretinoin | decreases expression | EXP | | 6480464 | Isotretinoin results in decreased expression of VMP1 mRNA | CTD | PMID:20436886 | L-methionine | multiple interactions | ISO | RGD:1619944 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VMP1 gene | CTD | PMID:20938992 | leflunomide | increases expression | ISO | RGD:70367 | 6480464 | leflunomide results in increased expression of VMP1 mRNA | CTD | PMID:24136188 | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of VMP1 mRNA | CTD | PMID:28988120 | levofloxacin | increases expression | ISO | RGD:70367 | 6480464 | Levofloxacin results in increased expression of VMP1 mRNA | CTD | PMID:24136188 | methyl beta-cyclodextrin | multiple interactions | EXP | | 6480464 | methyl-beta-cyclodextrin inhibits the reaction [Dehydroepiandrosterone results in increased expression of VMP1 mRNA] | CTD | PMID:25969534 | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of VMP1 mRNA | CTD | PMID:28001369 | N-methyl-4-phenylpyridinium | increases expression | ISO | RGD:70367 | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of VMP1 mRNA | CTD | PMID:16026605 | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of VMP1 mRNA | CTD | PMID:24768652, PMID:25583101 | nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of VMP1 mRNA | CTD | PMID:26378417 | oxaliplatin | multiple interactions | ISO | RGD:70367 | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of VMP1 mRNA | CTD | PMID:25729387 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of VMP1 mRNA | CTD | PMID:21420995 | phenobarbital | increases expression | ISO | RGD:70367 | 6480464 | Phenobarbital results in increased expression of VMP1 mRNA | CTD | PMID:19162173 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of VMP1 mRNA | CTD | PMID:19710929 | pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:1619944 | 6480464 | Pregnenolone Carbonitrile results in increased expression of VMP1 mRNA | CTD | PMID:28903501 | propiconazole | increases expression | ISO | RGD:1619944 | 6480464 | propiconazole results in increased expression of VMP1 mRNA | CTD | PMID:21278054 | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of VMP1 mRNA | CTD | PMID:30851411 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VMP1 mRNA | CTD | PMID:27188386 | sodium dichromate | increases expression | ISO | RGD:70367 | 6480464 | sodium bichromate results in increased expression of VMP1 mRNA | CTD | PMID:22561333 | sulindac sulfide | increases expression | EXP | | 6480464 | sulindac sulfide results in increased expression of VMP1 mRNA | CTD | PMID:12734198 | titanium dioxide | increases expression | ISO | RGD:1619944 | 6480464 | titanium dioxide results in increased expression of VMP1 mRNA | CTD | PMID:23557971, PMID:27760801 | topotecan | multiple interactions | ISO | RGD:70367 | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of VMP1 mRNA | CTD | PMID:25729387 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of VMP1 mRNA | CTD | PMID:26705709 | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of VMP1 mRNA | CTD | PMID:28542535 | trimellitic anhydride | increases expression | ISO | RGD:1619944 | 6480464 | trimellitic anhydride results in increased expression of VMP1 mRNA | CTD | PMID:19042947 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of VMP1 gene | CTD | PMID:29154799 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of VMP1 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of VMP1 mRNA | CTD | PMID:26272509, PMID:28001369 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VMP1 mRNA | CTD | PMID:27188386 | |
|
|
|
|
|
|
|
|
|
1. | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
2. | RGD automated import pipeline for gene-chemical interactions |
PubMed | 11076863 11230166 11256614 11785947 12477932 15466293 15489336 16381901 17724469 17940279 18384814 18550798 19019082 19056683 19322201 19490893 20299819 21173155 21467264 21873635 22144109 22333543 22404213 22535956 22971212 23118302 23316280 23460482 23710913 24365149 24623722 26186194 26328607 26638075 27023910 27415425 27861594 28514442 28890335 29180619 29507755 29509190 30093494 |
VMP1 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vmp1 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vmp1 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vmp1 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VMP1 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vmp1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
SHGC-64257 |
|
||||||||||||||||||||||||||||||||||||||||
RH91780 |
|
||||||||||||||||||||||||||||||||||||||||
G42203 |
|
||||||||||||||||||||||||||||||||||||||||
G42241 |
|
||||||||||||||||||||||||||||||||||||||||
G42376 |
|
||||||||||||||||||||||||||||||||||||||||
G42384 |
|
||||||||||||||||||||||||||||||||||||||||
RH46129 |
|
||||||||||||||||||||||||||||||||||||||||
RH48465 |
|
The detailed report is available here: | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer |
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
RefSeq Transcripts | NG_051107 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
NM_001329394 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001329395 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001329396 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001329397 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001329398 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001329399 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001329400 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001329401 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001329402 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_030938 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
GenBank Nucleotide | AB047551 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
AC004686 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AC025858 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AC040904 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AC091271 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AC244499 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AF161410 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AF214006 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK024969 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK025987 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK293578 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK293664 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK294854 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK301254 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL136711 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AX083452 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AX775965 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC009758 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC024020 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BM803108 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BQ002999 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CA412810 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CB216599 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CH471109 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CR533521 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
DC339443 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
DC428792 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
RefSeq Acc Id: | NM_001329394 ⟹ NP_001316323 | |||||||||
RefSeq Status: | REVIEWED | |||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
GACAAGTTCCGGATCAAGAATCACAAAGCGAGCAGTCATTCTTCCTCTTGCCACACCCACAGGGhide sequence |
RefSeq Acc Id: | NM_001329395 ⟹ NP_001316324 | |||||||||
RefSeq Status: | REVIEWED | |||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
GACAAGTTCCGGATCAAGAATCACAAAGCGAGCAGTCATTCTTCCTCTTGCCACACCCACAGGGhide sequence |
RefSeq Acc Id: | NM_001329396 ⟹ NP_001316325 | |||||||||
RefSeq Status: | REVIEWED | |||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
GACAAGTTCCGGATCAAGAATCACAAAGCGAGCAGTCATTCTTCCTCTTGCCACACCCACAGGGhide sequence |
RefSeq Acc Id: | NM_001329397 ⟹ NP_001316326 | |||||||||
RefSeq Status: | REVIEWED | |||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
GACAAGTTCCGGATCAAGAATCACAAAGCGAGCAGTCATTCTTCCTCTTGCCACACCCACAGGGhide sequence |
RefSeq Acc Id: | NM_001329398 ⟹ NP_001316327 | |||||||||
RefSeq Status: | REVIEWED | |||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
GACAAGTTCCGGATCAAGAATCACAAAGCGAGCAGTCATTCTTCCTCTTGCCACACCCACAGGGhide sequence |
RefSeq Acc Id: | NM_001329399 ⟹ NP_001316328 | |||||||||
RefSeq Status: | REVIEWED | |||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
GACAAGTTCCGGATCAAGAATCACAAAGCGAGCAGTCATTCTTCCTCTTGCCACACCCACAGGGhide sequence |
RefSeq Acc Id: | NM_001329400 ⟹ NP_001316329 | |||||||||
RefSeq Status: | REVIEWED | |||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
GACAAGTTCCGGATCAAGAATCACAAAGCGAGCAGTCATTCTTCCTCTTGCCACACCCACAGGGhide sequence |
RefSeq Acc Id: | NM_001329401 ⟹ NP_001316330 | |||||||||
RefSeq Status: | REVIEWED | |||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
GACAAGTTCCGGATCAAGAATCACAAAGCGAGCAGTCATTCTTCCTCTTGCCACACCCACAGGGhide sequence |
RefSeq Acc Id: | NM_001329402 ⟹ NP_001316331 | |||||||||
RefSeq Status: | REVIEWED | |||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
GACAAGTTCCGGATCAAGAATCACAAAGCGAGCAGTCATTCTTCCTCTTGCCACACCCACAGGGhide sequence |
RefSeq Acc Id: | NM_030938 ⟹ NP_112200 | ||||||||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||||
Sequence: |
GACAAGTTCCGGATCAAGAATCACAAAGCGAGCAGTCATTCTTCCTCTTGCCACACCCACAGGGhide sequence |
Protein RefSeqs | NP_001316323 | (Get FASTA) | NCBI Sequence Viewer |
NP_001316324 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001316325 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001316326 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001316327 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001316328 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001316329 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001316330 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001316331 | (Get FASTA) | NCBI Sequence Viewer | |
NP_112200 | (Get FASTA) | NCBI Sequence Viewer | |
GenBank Protein | AAF28970 | (Get FASTA) | NCBI Sequence Viewer |
AAH09758 | (Get FASTA) | NCBI Sequence Viewer | |
AAL36461 | (Get FASTA) | NCBI Sequence Viewer | |
BAF47368 | (Get FASTA) | NCBI Sequence Viewer | |
BAG57048 | (Get FASTA) | NCBI Sequence Viewer | |
BAG57110 | (Get FASTA) | NCBI Sequence Viewer | |
BAG57958 | (Get FASTA) | NCBI Sequence Viewer | |
BAG62821 | (Get FASTA) | NCBI Sequence Viewer | |
CAB66646 | (Get FASTA) | NCBI Sequence Viewer | |
CAC33315 | (Get FASTA) | NCBI Sequence Viewer | |
CAE11682 | (Get FASTA) | NCBI Sequence Viewer | |
CAG38552 | (Get FASTA) | NCBI Sequence Viewer | |
EAW94390 | (Get FASTA) | NCBI Sequence Viewer | |
EAW94391 | (Get FASTA) | NCBI Sequence Viewer | |
EAW94392 | (Get FASTA) | NCBI Sequence Viewer | |
EAW94393 | (Get FASTA) | NCBI Sequence Viewer | |
Q96GC9 | (Get FASTA) | NCBI Sequence Viewer |
RefSeq Acc Id: | NP_112200 ⟸ NM_030938 |
- Peptide Label: | isoform 1 |
- UniProtKB: | Q96GC9 (UniProtKB/Swiss-Prot) |
- Sequence: |
MAENGKNCDQRRVAMNKEHHNGNFTDPSSVNEKKRREREERQNIVLWRQPLITLQYFSLEILVIhide sequence |
RefSeq Acc Id: | NP_001316323 ⟸ NM_001329394 |
- Peptide Label: | isoform 1 |
- UniProtKB: | Q96GC9 (UniProtKB/Swiss-Prot) |
- Sequence: |
MAENGKNCDQRRVAMNKEHHNGNFTDPSSVNEKKRREREERQNIVLWRQPLITLQYFSLEILVIhide sequence |
RefSeq Acc Id: | NP_001316324 ⟸ NM_001329395 |
- Peptide Label: | isoform 2 |
- UniProtKB: | D3DU01 (UniProtKB/TrEMBL) |
- Sequence: |
MAENGKNCDQRRVAMNKEHHNGNFTDPSSVNEKKRREREERQNIVLWRQPLITLQYFSLEILVIhide sequence |
RefSeq Acc Id: | NP_001316326 ⟸ NM_001329397 |
- Peptide Label: | isoform 4 |
- UniProtKB: | Q96GC9 (UniProtKB/Swiss-Prot), B4DEJ9 (UniProtKB/TrEMBL) |
- Sequence: |
MAENGKNCDQRRVAMNKEHHNGNFTDPSSVNEKKRREREERQNIVLWRQPLITLQYFSLEILVIhide sequence |
RefSeq Acc Id: | NP_001316325 ⟸ NM_001329396 |
- Peptide Label: | isoform 3 |
- Sequence: |
MAENGKNCDQRRVAMNKEHHNGNFTDPSSVNEKKRREREERQNIVLWRQPLITLQYFSLEILVIhide sequence |
RefSeq Acc Id: | NP_001316327 ⟸ NM_001329398 |
- Peptide Label: | isoform 5 |
- Sequence: |
MDLKYVQRIEKQFLLYAYWIGLGILSSVGLGTGLHTFLLYLGPHIASVTLAAYECNSVNFPEPPhide sequence |
RefSeq Acc Id: | NP_001316328 ⟸ NM_001329399 |
- Peptide Label: | isoform 6 |
- UniProtKB: | B4DGZ7 (UniProtKB/TrEMBL) |
- Sequence: |
MDLKYVQRIEKQFLLYAYWIGLGILSSVGLGTGLHTFLLYLGPHIASVTLAAYECNSVNFPEPPhide sequence |
RefSeq Acc Id: | NP_001316330 ⟸ NM_001329401 |
- Peptide Label: | isoform 8 |
- Sequence: |
MDLKYVQRIEKQFLLYAYWIGLGILSSVGLGTGLHTFLLYLGIGTAIGELPPYFMARAARLSGAhide sequence |
RefSeq Acc Id: | NP_001316329 ⟸ NM_001329400 |
- Peptide Label: | isoform 7 |
- UniProtKB: | B4DED7 (UniProtKB/TrEMBL) |
- Sequence: |
MDLKGPHIASVTLAAYECNSVNFPEPPYPDQIICPDEEGTEGTISLWSIISKVRIEACMWGIGThide sequence |
RefSeq Acc Id: | NP_001316331 ⟸ NM_001329402 |
- Peptide Label: | isoform 9 |
- UniProtKB: | Q96GC9 (UniProtKB/Swiss-Prot) |
- Sequence: |
MWGIGTAIGELPPYFMARAARLSGAEPDDEEYQEFEEMLEHAESAQDFASRAKLAVQKLVQKVGhide sequence |
RGD ID: | 7235859 | |||||||||
Promoter ID: | EPDNEW_H23676 | |||||||||
Type: | initiation region | |||||||||
Name: | VMP1_2 | |||||||||
Description: | vacuole membrane protein 1 | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing. | |||||||||
Position: |
|
RGD ID: | 7235863 | |||||||||
Promoter ID: | EPDNEW_H23677 | |||||||||
Type: | initiation region | |||||||||
Name: | VMP1_1 | |||||||||
Description: | vacuole membrane protein 1 | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing. | |||||||||
Position: |
|
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 17q21.33-24.2(chr17:36449220-68170214)x3 | copy number gain | Hydrocephalus [RCV000050957]|See cases [RCV000050957] | Chr17:36449220..68170214 [GRCh38] Chr17:48563237..65936105 [GRCh37] Chr17:45918236..63677950 [NCBI36] Chr17:17q21.33-24.2 |
pathogenic |
GRCh38/hg38 17q23.2-25.3(chr17:36449220-83086677)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052483]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052483]|See cases [RCV000052483] | Chr17:36449220..83086677 [GRCh38] Chr17:58617905..81044553 [GRCh37] Chr17:55972687..78637842 [NCBI36] Chr17:17q23.2-25.3 |
pathogenic |
GRCh38/hg38 17q22-23.1(chr17:59481220-59756756)x1 | copy number loss | See cases [RCV000135625] | Chr17:59481220..59756756 [GRCh38] Chr17:57558581..57834117 [GRCh37] Chr17:54913363..55188899 [NCBI36] Chr17:17q22-23.1 |
likely pathogenic|uncertain significance |
GRCh38/hg38 17q23.1-25.1(chr17:36449220-75053130)x3 | copy number gain | See cases [RCV000137437] | Chr17:36449220..75053130 [GRCh38] Chr17:57595736..73049225 [GRCh37] Chr17:54950518..70560820 [NCBI36] Chr17:17q23.1-25.1 |
pathogenic |
GRCh38/hg38 17q22-23.1(chr17:57418806-59735464)x1 | copy number loss | See cases [RCV000140211] | Chr17:57418806..59735464 [GRCh38] Chr17:55496167..57812825 [GRCh37] Chr17:52851166..55167607 [NCBI36] Chr17:17q22-23.1 |
pathogenic |
NM_030938.5(VMP1):c.331_332del (p.Leu111fs) | deletion | Monoclonal B-Cell Lymphocytosis [RCV000208550] | Chr17:59738864..59738865 [GRCh38] Chr17:57816225..57816226 [GRCh37] Chr17:17q23.1 |
uncertain significance |
GRCh37/hg19 17q22-23.3(chr17:56321134-62080001)x3 | copy number gain | See cases [RCV000240364] | Chr17:56321134..62080001 [GRCh37] Chr17:17q22-23.3 |
pathogenic |
GRCh37/hg19 17q21.33-23.2(chr17:49076980-58740945)x3 | copy number gain | See cases [RCV000448805] | Chr17:49076980..58740945 [GRCh37] Chr17:17q21.33-23.2 |
pathogenic |
GRCh37/hg19 17q21.31-25.3(chr17:42580684-81085615)x3 | copy number gain | See cases [RCV000447823] | Chr17:42580684..81085615 [GRCh37] Chr17:17q21.31-25.3 |
pathogenic |
GRCh37/hg19 17p13.3-q25.3(chr17:526-81041938) | copy number gain | See cases [RCV000511439] | Chr17:526..81041938 [GRCh37] Chr17:17p13.3-q25.3 |
pathogenic |
GRCh37/hg19 17q22-23.2(chr17:56623275-60285107)x1 | copy number loss | See cases [RCV000511292] | Chr17:56623275..60285107 [GRCh37] Chr17:17q22-23.2 |
pathogenic |
GRCh37/hg19 17p13.3-q25.3(chr17:526-81041938)x3 | copy number gain | See cases [RCV000512441] | Chr17:526..81041938 [GRCh37] Chr17:17p13.3-q25.3 |
pathogenic |
GRCh37/hg19 17p13.3-q25.3(chr17:7214-81058310)x3 | copy number gain | not provided [RCV000739320] | Chr17:7214..81058310 [GRCh37] Chr17:17p13.3-q25.3 |
pathogenic |
GRCh37/hg19 17p13.3-q25.3(chr17:12344-81057996)x3 | copy number gain | not provided [RCV000739325] | Chr17:12344..81057996 [GRCh37] Chr17:17p13.3-q25.3 |
pathogenic |
GRCh37/hg19 17p13.3-q25.3(chr17:8547-81060040)x3 | copy number gain | not provided [RCV000739324] | Chr17:8547..81060040 [GRCh37] Chr17:17p13.3-q25.3 |
pathogenic |
GRCh37/hg19 17q23.1(chr17:57817697-57955754)x3 | copy number gain | not provided [RCV000739625] | Chr17:57817697..57955754 [GRCh37] Chr17:17q23.1 |
benign |
GRCh37/hg19 17q22-23.1(chr17:57582867-58080569)x3 | copy number gain | not provided [RCV000752157] | Chr17:57582867..58080569 [GRCh37] Chr17:17q22-23.1 |
benign |
GRCh37/hg19 17q22-24.2(chr17:57357088-66306668) | copy number gain | not provided [RCV000767764] | Chr17:57357088..66306668 [GRCh37] Chr17:17q22-24.2 |
pathogenic |
GRCh37/hg19 17q23.1-24.2(chr17:57869604-67078443)x3 | copy number gain | not provided [RCV000845965] | Chr17:57869604..67078443 [GRCh37] Chr17:17q23.1-24.2 |
pathogenic |
Database | Acc Id | Source(s) |
AGR Gene | HGNC:29559 | AgrOrtholog |
COSMIC | VMP1 | COSMIC |
Ensembl Genes | ENSG00000062716 | ENTREZGENE, UniProtKB/Swiss-Prot |
Ensembl Protein | ENSP00000262291 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENSP00000465397 | UniProtKB/TrEMBL | |
ENSP00000465911 | UniProtKB/TrEMBL | |
ENSP00000465947 | UniProtKB/TrEMBL | |
ENSP00000465972 | UniProtKB/TrEMBL | |
ENSP00000466198 | UniProtKB/TrEMBL | |
ENSP00000466413 | UniProtKB/TrEMBL | |
ENSP00000466511 | UniProtKB/TrEMBL | |
ENSP00000466579 | UniProtKB/TrEMBL | |
ENSP00000467093 | UniProtKB/TrEMBL | |
ENSP00000467350 | ENTREZGENE, UniProtKB/TrEMBL | |
Ensembl Transcript | ENST00000262291 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENST00000585847 | UniProtKB/TrEMBL | |
ENST00000586245 | UniProtKB/TrEMBL | |
ENST00000587259 | UniProtKB/TrEMBL | |
ENST00000587945 | UniProtKB/TrEMBL | |
ENST00000589823 | UniProtKB/TrEMBL | |
ENST00000591315 | UniProtKB/TrEMBL | |
ENST00000591877 | ENTREZGENE, UniProtKB/TrEMBL | |
ENST00000592106 | UniProtKB/TrEMBL | |
ENST00000592619 | UniProtKB/TrEMBL | |
ENST00000593168 | UniProtKB/TrEMBL | |
GTEx | ENSG00000062716 | GTEx |
HGNC ID | HGNC:29559 | ENTREZGENE |
Human Proteome Map | VMP1 | Human Proteome Map |
InterPro | SNARE_assoc | UniProtKB/Swiss-Prot |
KEGG Report | hsa:81671 | UniProtKB/Swiss-Prot |
NCBI Gene | 81671 | ENTREZGENE |
OMIM | 611753 | OMIM |
Pfam | SNARE_assoc | UniProtKB/Swiss-Prot |
PharmGKB | PA142670765 | PharmGKB |
UniGene | Hs.444569 | ENTREZGENE |
Hs.708260 | ENTREZGENE | |
Hs.743288 | ENTREZGENE | |
UniProt | B4DED7 | ENTREZGENE, UniProtKB/TrEMBL |
B4DEJ9 | ENTREZGENE, UniProtKB/TrEMBL | |
B4DGZ7 | ENTREZGENE, UniProtKB/TrEMBL | |
D3DU01 | ENTREZGENE, UniProtKB/TrEMBL | |
K7EK01_HUMAN | UniProtKB/TrEMBL | |
K7EL46_HUMAN | UniProtKB/TrEMBL | |
K7EL74_HUMAN | UniProtKB/TrEMBL | |
K7EL93_HUMAN | UniProtKB/TrEMBL | |
K7ELS2_HUMAN | UniProtKB/TrEMBL | |
K7EM96_HUMAN | UniProtKB/TrEMBL | |
K7EMI0_HUMAN | UniProtKB/TrEMBL | |
K7EMN6_HUMAN | UniProtKB/TrEMBL | |
K7ENU2_HUMAN | UniProtKB/TrEMBL | |
K7EPE7_HUMAN | UniProtKB/TrEMBL | |
Q96GC9 | ENTREZGENE, UniProtKB/Swiss-Prot | |
UniProt Secondary | B4DVV9 | UniProtKB/Swiss-Prot |
Q9H0P4 | UniProtKB/Swiss-Prot | |
Q9P089 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2011-07-27 | VMP1 | vacuole membrane protein 1 | TMEM49 | transmembrane protein 49 | Symbol and/or name change | 5135510 | APPROVED |
![]() |
More on VMP1 | |
![]() |
Alliance Gene |
![]() |
NCBI Gene |
![]() |
Ensembl Gene |
![]() |
JBrowse: hg19 hg38 |
![]() |
HGNC Report |
![]() |
NCBI Genome Data Viewer |
CRRD Object Information | |
CRRD ID: | 731420 |
Created: | 2004-01-12 |
Species: | Homo sapiens |
Last Modified: | 2019-11-26 |
Status: | ACTIVE |
![]() |
![]() |
![]() |
![]() |
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.